Trials / Completed
CompletedNCT01720576
Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1033 (SAR391786)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Regeneron Pharmaceuticals · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Accepted
Summary
This is a study to assess the safety and tolerability of subcutaneously administered REGN1033 (SAR391786) in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | REGN1033 (SAR391786) | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2012-11-02
- Last updated
- 2013-09-12
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01720576. Inclusion in this directory is not an endorsement.